Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 106 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action.
Cerro-Herreros E, Núñez-Manchón J, Naldaiz-Gastesi N, Carrascosa-Sàez M, García-Rey A, Losilla DP, González-Martínez I, Espinosa-Espinosa J, Moreno K, Poyatos-García J, Vilchez JJ, de Munain AL, Suelves M, Nogales-Gadea G, Llamusí B, Artero R
Sci Adv, 10(41):eadn6525, 09 Oct 2024
Cited by: 0 articles | PMID: 39383229 | PMCID: PMC11463307
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Gut Microbiota Involvement in the Panorama of Muscular Dystrophy Pathogenesis.
Russo C, Surdo S, Valle MS, Malaguarnera L
Int J Mol Sci, 25(20):11310, 21 Oct 2024
Cited by: 0 articles | PMID: 39457092 | PMCID: PMC11508360
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CTG repeat length underlying cardiac events and sudden death in myotonic dystrophy type 1.
Itoh H, Hisamatsu T, Segawa K, Takahashi T, Sato T, Takada H, Kuru S, Wada C, Suzuki M, Tamura T, Suwazono S, Kimura K, Matsumura T, Takahashi MP
Eur Heart J Open, 4(5):oeae078, 18 Sep 2024
Cited by: 0 articles | PMID: 39391712 | PMCID: PMC11465163
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Ameliorated cellular hallmarks of myotonic dystrophy in hybrid myotubes from patient and unaffected donor cells.
Raaijmakers RHL, Ausems CRM, Willemse M, Cumming SA, van Engelen BGM, Monckton DG, van Bokhoven H, Wansink DG
Stem Cell Res Ther, 15(1):302, 15 Sep 2024
Cited by: 0 articles | PMID: 39278936 | PMCID: PMC11403792
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Association between Reported Sleep Disorders and Behavioral Issues in Children with Myotonic Dystrophy Type 1-Results from a Retrospective Analysis in Italy.
Trucco F, Lizio A, Roma E, di Bari A, Salmin F, Albamonte E, Casiraghi J, Pozzi S, Becchiati S, Antonaci L, Salvalaggio A, Catteruccia M, Tosi M, Marinella G, Danti FR, Bruschi F, Veneruso M, Parravicini S, Fiorillo C, [...] Sansone VA
J Clin Med, 13(18):5459, 14 Sep 2024
Cited by: 0 articles | PMID: 39336946 | PMCID: PMC11432637
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2.
Krieger B, Schneider-Gold C, Genç E, Güntürkün O, Prehn C, Bellenberg B, Lukas C
J Neurol, 271(8):5525-5540, 19 Jun 2024
Cited by: 0 articles | PMID: 38896263 | PMCID: PMC11319366
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Heterogeneity of cognitive impairments in myotonic dystrophy type 1 explained by three distinct cognitive profiles.
Davion JB, Tard C, Fragoso L, Wilu-Wilu A, Skrobala E, Defebvre L, Delbeuck X
J Neurol, 271(7):4529-4539, 06 May 2024
Cited by: 0 articles | PMID: 38709306
Add to export list
Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1.
Mahdavi M, Prévost K, Balthazar P, Hus IF, Duchesne É, Dumont N, Gagné-Ouellet V, Gagnon C, Laforest-Lapointe I, Massé E
Comput Struct Biotechnol J, 23:2097-2108, 09 May 2024
Cited by: 1 article | PMID: 38803516 | PMCID: PMC11128782
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cognitive impairment, neuroimaging abnormalities, and their correlations in myotonic dystrophy: a comprehensive review.
Wu Y, Wei Q, Lin J, Shang H, Ou R
Front Cell Neurosci, 18:1369332, 04 Apr 2024
Cited by: 0 articles | PMID: 38638300 | PMCID: PMC11024338
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Role of Cognition, Affective Symptoms, and Apathy in Treatment Adherence with Noninvasive Home Mechanical Ventilation in Myotonic Dystrophy.
Vosse BAH, de Jong J, la Fontaine LA, Horlings CGC, van Kuijk SMJ, Cobben NAM, Domensino AF, van Heugten C, Faber CG
J Neuromuscul Dis, 11(5):1123-1130, 01 Jan 2024
Cited by: 0 articles | PMID: 39093078 | PMCID: PMC11380258
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study.
Roussel MP, Ravel-Chapuis A, Gobin J, Jasmin BJ, Leduc-Gaudet JP, Gagnon C, Duchesne E
J Neuromuscul Dis, 11(5):981-995, 01 Jan 2024
Cited by: 0 articles | PMID: 39031377 | PMCID: PMC11380274
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Unlocking the Complexity of Neuromuscular Diseases: Insights from Human Pluripotent Stem Cell-Derived Neuromuscular Junctions.
Gazzola M, Martinat C
Int J Mol Sci, 24(20):15291, 18 Oct 2023
Cited by: 3 articles | PMID: 37894969 | PMCID: PMC10607237
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
In Cis Effect of DMPK Expanded Alleles in Myotonic Dystrophy Type 1 Patients Carrying Variant Repeats at 5' and 3' Ends of the CTG Array.
Visconti VV, Macrì E, D'Apice MR, Centofanti F, Massa R, Novelli G, Botta A
Int J Mol Sci, 24(12):10129, 14 Jun 2023
Cited by: 0 articles | PMID: 37373276 | PMCID: PMC10299395
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clearance of defective muscle stem cells by senolytics restores myogenesis in myotonic dystrophy type 1.
Conte TC, Duran-Bishop G, Orfi Z, Mokhtari I, Deprez A, Côté I, Molina T, Kim TY, Tellier L, Roussel MP, Maggiorani D, Benabdallah B, Leclerc S, Feulner L, Pellerito O, Mathieu J, Andelfinger G, Gagnon C, Beauséjour C, [...] Dumont NA
Nat Commun, 14(1):4033, 19 Jul 2023
Cited by: 6 articles | PMID: 37468473 | PMCID: PMC10356779
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells.
Porquet F, Weidong L, Jehasse K, Gazon H, Kondili M, Blacher S, Massotte L, Di Valentin E, Furling D, Gillet NA, Klein AF, Seutin V, Willems L
Mol Ther Nucleic Acids, 32:857-871, 13 May 2023
Cited by: 2 articles | PMID: 37273786 | PMCID: PMC10238591
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1.
Nguyen CDL, Jimenez-Moreno AC, Merker M, Bowers CJ, Nikolenko N, Hentschel A, Müntefering T, Isham A, Ruck T, Vorgerd M, Dobelmann V, Gourdon G, Schara-Schmidt U, Gangfuss A, Schröder C, Sickmann A, Gross C, Gorman G, Stenzel W, [...] Roos A
J Neurol, 270(6):3138-3158, 09 Mar 2023
Cited by: 1 article | PMID: 36892629
Add to export list
Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data.
Carey IM, Nirmalananthan N, Harris T, DeWilde S, Chaudhry UAR, Limb E, Cook DG
PLoS One, 18(3):e0282513, 01 Mar 2023
Cited by: 2 articles | PMID: 36857388 | PMCID: PMC9977045
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Automatic Text-Mining Approach to Identify Molecular Target Candidates Associated with Metabolic Processes for Myotonic Dystrophy Type 1.
Kuntawala DH, Martins F, Vitorino R, Rebelo S
Int J Environ Res Public Health, 20(3):2283, 27 Jan 2023
Cited by: 1 article | PMID: 36767649 | PMCID: PMC9915907
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1.
Joosten IBT, Janssen CEW, Horlings CGC, den Uijl D, Evertz R, van Engelen BGM, Faber CG, Vernooy K
Europace, 25(1):156-163, 01 Feb 2023
Cited by: 1 article | PMID: 35851806 | PMCID: PMC9907751
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Resistance Exercise Training Rescues Mitochondrial Dysfunction in Skeletal Muscle of Patients with Myotonic Dystrophy Type 1.
Di Leo V, Lawless C, Roussel MP, Gomes TB, Gorman GS, Russell OM, Tuppen HAL, Duchesne E, Vincent AE
J Neuromuscul Dis, 10(6):1111-1126, 01 Jan 2023
Cited by: 3 articles | PMID: 37638448 | PMCID: PMC10657683
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Nuclear envelope transmembrane proteins involved in genome organization are misregulated in myotonic dystrophy type 1 muscle.
Todorow V, Hintze S, Schoser B, Meinke P
Front Cell Dev Biol, 10:1007331, 09 Jan 2023
Cited by: 1 article | PMID: 36699009 | PMCID: PMC9868253
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1).
Rossi S, Silvestri G
Int J Mol Sci, 24(3):2204, 22 Jan 2023
Cited by: 2 articles | PMID: 36768526 | PMCID: PMC9917343
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Myotonic dystrophy type 1: A comparison between the adult- and late-onset subtype.
Joosten IBT, Horlings CGC, Vosse BAH, Wagner A, Bovenkerk DSH, Evertz R, Vernooy K, van Engelen BGM, Faber CG
Muscle Nerve, 67(2):130-137, 22 Dec 2022
Cited by: 2 articles | PMID: 36484161 | PMCID: PMC10107795
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
In Vivo Parieto-Occipital White Matter Metabolism Is Correlated with Visuospatial Deficits in Adult DM1 Patients.
Evangelisti S, Gramegna LL, De Pasqua S, Rochat MJ, Morandi L, Mitolo M, Bianchini C, Vornetti G, Testa C, Avoni P, Liguori R, Lodi R, Tonon C
Diagnostics (Basel), 12(10):2305, 24 Sep 2022
Cited by: 3 articles | PMID: 36291994 | PMCID: PMC9600392
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical and neuroimaging review of triplet repeat diseases.
Kurokawa R, Kurokawa M, Mitsutake A, Nakaya M, Baba A, Nakata Y, Moritani T, Abe O
Jpn J Radiol, 41(2):115-130, 28 Sep 2022
Cited by: 3 articles | PMID: 36169768 | PMCID: PMC9889482
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 106 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action.

The Gut Microbiota Involvement in the Panorama of Muscular Dystrophy Pathogenesis.

CTG repeat length underlying cardiac events and sudden death in myotonic dystrophy type 1.

Ameliorated cellular hallmarks of myotonic dystrophy in hybrid myotubes from patient and unaffected donor cells.

Association between Reported Sleep Disorders and Behavioral Issues in Children with Myotonic Dystrophy Type 1-Results from a Retrospective Analysis in Italy.

Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2.

Heterogeneity of cognitive impairments in myotonic dystrophy type 1 explained by three distinct cognitive profiles.

Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1.

Cognitive impairment, neuroimaging abnormalities, and their correlations in myotonic dystrophy: a comprehensive review.

The Role of Cognition, Affective Symptoms, and Apathy in Treatment Adherence with Noninvasive Home Mechanical Ventilation in Myotonic Dystrophy.

Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study.

Unlocking the Complexity of Neuromuscular Diseases: Insights from Human Pluripotent Stem Cell-Derived Neuromuscular Junctions.

In Cis Effect of DMPK Expanded Alleles in Myotonic Dystrophy Type 1 Patients Carrying Variant Repeats at 5' and 3' Ends of the CTG Array.

Clearance of defective muscle stem cells by senolytics restores myogenesis in myotonic dystrophy type 1.

Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells.

Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1.

Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data.

Automatic Text-Mining Approach to Identify Molecular Target Candidates Associated with Metabolic Processes for Myotonic Dystrophy Type 1.

An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1.

Resistance Exercise Training Rescues Mitochondrial Dysfunction in Skeletal Muscle of Patients with Myotonic Dystrophy Type 1.

Nuclear envelope transmembrane proteins involved in genome organization are misregulated in myotonic dystrophy type 1 muscle.

Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1).

Myotonic dystrophy type 1: A comparison between the adult- and late-onset subtype.

In Vivo Parieto-Occipital White Matter Metabolism Is Correlated with Visuospatial Deficits in Adult DM1 Patients.

Clinical and neuroimaging review of triplet repeat diseases.

Partnerships & funding